2m 2m 2m 2m 2m 2m 2m
Corcept Therapeu (CORT)
NASDAQ
$121.18-$1.07 (-0.88%)
Price as of Aug 21, 2026 7:58 PM EDT- $13.2BMarket Cap
- 73.82%1-Year Change
- BiotechnologyIndustry
Corcept Therapeu (CORT)
$121.18-$1.07 (-0.88%)
CORT | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $122.25 | ||
Change | +$1.20 (+0.99%) | ||
Open | $121.48 | ||
High | $123.44 | ||
Low | $120.56 | ||
Previous Close | $121.05 | ||
Volume | 656,444 | ||
30-Day Average Volume | 1,154,912 | ||
1-Week Change | 6.80% | ||
1-Month Change | 27.81% | ||
1-Year Change | 73.82% | ||
3-Year Change | 289.08% | ||
5-Year Change | 493.45% | ||
Fundamentals | |||
Shares Outstanding | 108.1M | ||
Total Assets | $888.7M | ||
Market Cap | $13.2B | ||
Enterprise Value | $13.1B | ||
Period: QTR TTM FY | |||
Revenue | $256.1M | ||
Net Income | $43.0M | ||
Free Cash Flow | $31.0M | ||
EBIT | $45.9M | ||
EBITDA | $46.8M | ||
Net Working Capital | $285.9M | ||
EPS | $0.36 | ||
Enterprise Value/EBITDA | 280 | ||
Enterprise Value/Revenue | 51 | ||
P/B | 19 | ||
P/E | 340 | ||
PEG | 2 | ||
Price/Free Cash Flow | 426 | ||
Price/Operating Cash Flow | 394 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue